Turn Therapeutics Inc. — Form 8-K
Filed August 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Turn Therapeutics filed an 8-K on 2026-08-17 covering period 2026-08-14. The filing contains only Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits) with no material facts, dollar amounts, counterparties, or business developments disclosed in the accessible text. The document consists primarily of XBRL formatting files and metadata without narrative disclosure of any transaction, agreement, or material event.
Why this rating
No material business event disclosed; routine administrative 8-K filing with boilerplate structure only.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from August 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.